Ding et al., reported similar prevalence of EZH2 expression according to the pathological diagnosis and outcome (tumor development) to ours, and Kunju et al., reported an impressive area under the receiver operator curve (AUC) of 0.88 for the ability of EZH2 to predict breast cancer. The gene discussed is EZH2; the disease is breast carcinoma.